title: Identification of novel mutations in Spanish patients with muscle carnitine palmitoyltransferase II deficiency.
abstract: Carnitine palmitoyltransferase II (CPT II) deficiency is the most common recessively inherited disorder of lipid metabolism affecting skeletal muscle and the most frequent cause of hereditary myoglobinuria. We studied 5 Spanish patients with CPT II deficiency from four unrelated families. Four patients had the typical clinical phenotype of muscle CPT II deficiency with recurrent episodes of myoglobinuria, triggered by prolonged exercise, fasting, or fever, and marked elevation of creatine kinase values during metabolic crisis. One patient had exercise-related myalgia, cramps and moderate elevation of serum CK values, but had never had myoglobinuria. Molecular analysis showed that three patients were heterozygous for the S113L mutation and one patient heterozygous for the P50H substitution. To identify the mutations in the other alleles of our patients we amplified and sequenced genomic DNA fragments encompassing the entire coding region and intron/exon boundaries of the CPT2 gene. We found the recently reported 178 insT/del 25 bp in one patient. Three novel mutations were identified: a Y120C substitution that leads to a nonconservative amino acid replacement; a 36-38 insGC mutation that results in premature termination of the translation; and an I502T substitution that affects a conserved amino acid residue in the CPT II protein. Our data confirm the molecular heterogeneity of patients with CPT II deficiency, and suggest that the ethnic origin has to be taken into account before performing mutation analysis in these patients.
authors.affiliation: Centro de Investigación, Hospital Universitario 12 de Octubre, Madrid, Spain.
authors.forename: M A
authors.initials: MA
authors.lastname: Martín
authors.forename: J C
authors.initials: JC
authors.lastname: Rubio
authors.forename: P
authors.initials: P
authors.lastname: del Hoyo
authors.forename: A
authors.initials: A
authors.lastname: García
authors.forename: F
authors.initials: F
authors.lastname: Bustos
authors.forename: Y
authors.initials: Y
authors.lastname: Campos
authors.forename: A
authors.initials: A
authors.lastname: Cabello
authors.forename: J M
authors.initials: JM
authors.lastname: Culebras
authors.forename: J
authors.initials: J
authors.lastname: Arenas
mesh_terms: D000293:Adolescent; D000328:Adult; D002334:Carnitine O-Palmitoyltransferase / Q000097:blood / Q000172:deficiency* / Q000235:genetics*; D002648:Child; D003402:Creatine Kinase / Q000097:blood; D005260:Female; D006801:Humans; D008052:Lipid Metabolism, Inborn Errors / Q000097:blood / Q000201:enzymology* / Q000235:genetics*; D008297:Male; D018482:Muscle, Skeletal / Q000201:enzymology* / Q000378:metabolism*; D009154:Mutation / Q000235:genetics*; D010375:Pedigree; D013030:Spain
chemical_list: D002334:Carnitine O-Palmitoyltransferase; D003402:Creatine Kinase